News

SeeLuma is a “Fully Digital Surgical Visualization Platform” to assist ophthalmic surgeons.

According to the company, KPI-012 could become the first approved treatment for persistent corneal epithelial defect across all its various etiologies.

The study compared eyes with retinopathy of prematurity (ROP) that were treated with laser and age-matched control eyes without ROP.

Esen Akpek, MD, sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss ocular surface disease and the lifestyle choices that could affect eye health. As well as what The Tear Film & Ocular Surface Society is doing to promote research on the topic.

A research team made up of scientists from a trio of European universities and led by a Northumbria University academic, has received funding to research age-related macular degeneration.

Patients and employees, past and present, have had personal and protected health information acquired without authorization.

If no comment from the FDA is received within 30 days, the company said it will initiate the BRM424 phase 2 study in the first half of 2023.

According to data, 62% of patients treated with teprotumumab-trbw had a clinically meaningful improvement in proptosis at Week 24compared with 25% of patients receiving placebo.

The ESSENCE-2 study showed a significantly greater reduction in the total corneal fluorescein staining (tCFS) score.

One way to advance the current understanding of GA is to study how disease progression varies among related individuals.

A team of researchers has uncovered a mechanism that causes blindness, could lead to targeted therapies.

According to National Eye Institute researchers, the variants generate malformed proteins that alter the stability of the membrane attack complex, which may drive a chronic inflammatory response in the retina.

A study shows Atropine 0.01% eye drops decreased myopia progression in children over the course of 1 year.

Ophthalmologists can learn the latest techniques to help patients like Tommy Pham from the New York Mets during the first annual IKA Keratoconus Symposium: Front to Back and Everything In Between, taking place April 22-23 in Scottsdale, Arizona.

Eye rubbing is a common practice, but one that can cause a number of problems.

Eyenuk Inc. founder and CEO Kaushal Solanki, PhD, went from working for the Defense Department to founding a company with a focus on artificial intelligence for ophthalmology. Find out what led him to make that jump.

By crossing into the retina, investigators have uncovered a new DHA supplement achieves what previous ones could not.

Intimate partner violence awareness in ophthalmologists can be heightened thanks to a recent study.

Alice Epitropoulos, MD, goes over some tips and methods to educate patients about OSD before performing any surgery.

SMSGOP and SMGOP are two models of artificial intelligence that can predict progression of Graves’ orbitopathy.

Retinal redetachment can occur frequently in eyes that underwent repair of rhegmatogenous retinal detachments (RRDs) after infectious endophthalmitis.

A successful career in ophthalmology may seem daunting to a young trainee, but Real World Ophthalmology is here to reveal the secrets.

Dirty equipment and sterilization issues are among the many violations found by the FDA.

Technology offers accessibility, scalability to countries where care is needed the most.

Cochair Elizabeth Yeu, MD, highlights what this program will mean for ophthalmologists, optometrists, and their patients.

Lisa M. Nijm, MD, MD, highlights what residents, fellows, and ophthalmologists who are early in their careers can expect at the virtual Real World Ophthalmology meeting on Saturday, April 15.

The company could also consider partnerships or licensing agreements for some drugs of its ophthalmology pipeline, including pegcetacoplan.

Despite the injection of intravitreal antibiotics at the end of corrective surgery, delayed-onset endophthalmitis can develop in patients who sustained open globe injuries.

Evolving technology is resulting in better outcomes for patients.